Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 5.04%20.03B | 0.07%19.07B | 4.45%5.92B | 11.14%4.34B | -15.70%4.51B | 4.02%4.3B | 3.68%19.06B | -9.25%5.67B | -4.19%3.91B | 25.80%5.35B |
| Cost of revenue | 7.58%17.13B | -2.73%15.93B | -1.49%5.03B | 10.41%3.62B | -17.89%3.67B | 2.49%3.61B | 9.00%16.37B | -1.70%5.11B | -2.15%3.28B | 30.94%4.47B |
| Gross profit | -7.78%2.9B | 17.13%3.15B | 58.63%888.69M | 14.97%725.91M | -4.67%842.35M | 12.82%690.5M | -20.10%2.69B | -46.64%560.24M | -13.53%631.38M | 4.97%883.59M |
| Operating expense | 1.76%3.1B | -4.32%3.05B | -3.79%782.93M | -3.76%753.56M | -8.08%749.44M | -1.48%762.8M | 0.77%3.19B | 9.39%813.78M | -2.02%783.02M | 1.27%815.27M |
| Operating profit | -302.47%-199.91M | 119.78%98.73M | 141.71%105.76M | 81.77%-27.64M | 36.01%92.91M | 55.45%-72.3M | -347.77%-499.15M | -182.85%-253.54M | -119.75%-151.65M | 86.34%68.32M |
| Net non-operating interest income (expenses) | -56.81%536K | 288.89%1.24M | 9,690.91%1.06M | 530.45%947K | -315.48%-349K | -20.47%-412K | -532.24%-657K | 95.53%-11K | -201.38%-220K | -594.12%-84K |
| Non-operating interest income | 17.16%3.95M | 91.64%3.37M | 165.08%1.56M | 199.78%1.35M | -41.61%268K | -26.54%191K | 2.21%1.76M | 64.35%590K | -13.65%449K | 16.79%459K |
| Non-operating interest expense | 60.29%3.41M | -11.88%2.13M | -15.31%509K | -40.36%399K | 13.63%617K | 0.17%603K | 54.02%2.42M | -0.66%601K | 120.79%669K | 44.41%543K |
| Net investment income | -86.46%5.61M | 75.22%41.42M | 328.07%18.64M | -53.95%-44.22M | 1.13%16.18M | 58.77%50.82M | 228.73%23.64M | -27.25%4.35M | -84,588.24%-28.73M | 20,951.32%16M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | -2,168.18%-910K | 102.05%44K | 103.19%13K | 0 | 101.02%18K | 85.71%13K | -812.77%-2.15M | -314.74%-408K | 105.45%18K | -19,477.78%-1.76M |
| Special income (charges) | 3,857.70%19.27M | -91.66%487K | -72.94%1.58M | -1.72M | 3.27M | -2.64M | 101.29%5.84M | 101.29%5.84M | 0 | 0 |
| Less:Restructuring and mergern&acquisition | -180.46%-3.33M | --4.14M | --0 | --2.14M | ---648K | --2.64M | --0 | --0 | --0 | --0 |
| Less:Other special charges | -229.22%-16.23M | 36.96%-4.93M | ---1.88M | ---428K | ---- | ---- | ---7.82M | ---- | ---- | ---- |
| Less:Write off | -4.28%291K | -84.69%304K | ---- | ---- | ---- | ---- | -99.56%1.99M | ---- | ---- | ---- |
| Other non-operating income (expenses) | 560.64%50.9M | 86.79%7.71M | -28.21%1.27M | 136.93%1.38M | 231.28%3.92M | -76.83%1.14M | -21.37%4.13M | 126.79%1.77M | -565.01%-3.73M | -41.26%1.18M |
| Income before tax | -183.21%-124.5M | 131.95%149.63M | 153.02%128.32M | 61.34%-71.26M | 38.61%115.95M | 81.40%-23.38M | -95.09%-468.35M | -71.28%-242M | -169.91%-184.31M | 115.52%83.65M |
| Income tax | -6.22%33.52M | -1.46%35.75M | -33.41%5.42M | -0.28%9.29M | 2.56%9M | 19.85%12.03M | -23.20%36.27M | -39.99%8.14M | -3.89%9.31M | -10.28%8.78M |
| Net income | -238.76%-158.02M | 122.57%113.88M | 149.13%122.89M | 58.40%-80.54M | 42.84%106.94M | 73.91%-35.41M | -75.64%-504.63M | -61.53%-250.14M | -148.31%-193.62M | 157.92%74.87M |
| Net income continuous operations | -238.76%-158.02M | 122.57%113.88M | 149.13%122.89M | 58.40%-80.54M | 42.84%106.94M | 73.91%-35.41M | -75.64%-504.62M | -61.53%-250.14M | -148.31%-193.62M | 157.92%74.87M |
| Noncontrolling interests | -27.95%29.38M | 298.14%40.78M | 1,600.12%12.53M | 47.50%-5.77M | 115.78%14.73M | 26.62%19.29M | 70.76%10.24M | -115.11%-835K | -822.86%-10.98M | 3,042.67%6.83M |
| Net income attributable to the company | -356.36%-187.4M | 114.20%73.1M | 144.27%110.37M | 59.06%-74.78M | 35.52%92.21M | 63.77%-54.7M | -75.54%-514.87M | -55.45%-249.3M | -137.86%-182.64M | 132.53%68.04M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -356.36%-187.4M | 114.20%73.1M | 144.27%110.37M | 59.06%-74.78M | 35.52%92.21M | 63.77%-54.7M | -75.54%-514.87M | -55.45%-249.3M | -137.86%-182.64M | 132.53%68.04M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -356.09%-9.04 | 114.19%3.53 | 144.23%5.33 | 59.07%-3.61 | 35.26%4.45 | 63.84%-2.64 | -75.33%-24.88 | -55.28%-12.05 | -137.74%-8.82 | 133.33%3.29 |
| Diluted earnings per share | -356.09%-9.04 | 114.19%3.53 | 144.18%5.3239 | 59.14%-3.61 | 35.20%4.4481 | 63.84%-2.64 | -75.33%-24.88 | -55.28%-12.05 | -137.87%-8.8358 | 133.33%3.29 |
| Dividend per share | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |